6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party. (Q36403174)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

17 January 2020

main subject

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sven Almer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

N K H de Boer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

W Reinisch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A Teml

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A A van Bodegraven

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M Schwab

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

T Ochsenkühn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

W Petritsch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

P Knoflach

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S W van der Merwe

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

K R Herrlinger

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J Seiderer

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

H Vogelsang

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

C J J Mulder

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Dutch 6-TG working group

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

21 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

25-31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16493198%20AND%20SRC:MED&resulttype=core&format=json

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

17 January 2020

cites work

1 reference

6-thioguanine can cause serious liver injury in inflammatory bowel disease patients

21 January 2018

1 reference

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

21 January 2018

1 reference

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

21 January 2018

1 reference

An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy

21 January 2018

1 reference

Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine

21 January 2018

1 reference

On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients

21 January 2018

1 reference